The Business of Weed
Own Pots Stocks? Midas Letter – CB1 Capital: Cannabis Could be $3 Trillion Market
CB1 Capital is a hedge fund that invests in efficacy-driven cannabinoid wellness strategies. CIO Todd Harrison explains that CB1 Capital is interested in companies that present investment opportunities featuring a variety of minor cannabinoids, such as CBM for sleep, and not just CBD. CB1 Capital has one third of its capital invested in Canada right now and Harrison suggests biotech is about to take the leading role in efficacy-driven wellness solutions. Cannabis is currently a $300 billion cash crop and Harrison believes, with the development of new products and greater adoption, the industry could soar to be a $2-3 trillion market.
Watch – CB1 Capital: Cannabis Could be $3 Trillion Market

